Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer
Authors:
Open Access
- 20 April 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (4) , 1223
Abstract
Triple-negative breast cancer (TNBC), characterized by a deficiency in estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor2 (HER2), is among the most lethal subtypes of breast cancer (BC). Nevertheless, the molecular determinants that contribute to its malignant phenotypes such as tumor heterogeneity and therapy resistance, remain elusive. In this study, we sought to identify the stemness-associated genes involved in TNBC progression. Using bioinformatics approaches, we found 55 up- and 9 downregulated genes in TNBC. Out of the 55 upregulated genes, a 5 gene-signature (CDK1, EZH2, CCNB1, CCNA2, and AURKA) involved in cell regeneration was positively correlated with the status of tumor hypoxia and clustered with stemness-associated genes, as recognized by Parametric Gene Set Enrichment Analysis (PGSEA). Enhanced infiltration of immunosuppressive cells was also positively correlated with the expression of these five genes. Moreover, our experiments showed that depletion of the transcriptional co-factor nucleus accumbens-associated protein 1 (NAC1), which is highly expressed in TNBC, reduced the expression of these genes. Thus, the five genes signature identified by this study warrants further exploration as a potential new biomarker of TNBC heterogeneity/stemness characterized by high hypoxia, stemness enrichment, and immune-suppressive tumor microenvironment.Keywords
All Related Versions
Funding Information
- National Cancer Institute (5R01CA221867, CCR18548501, P20GM121327)
- Susan G. Komen for the Cure (5R01CA221867, CCR18548501, P20GM121327)
- National Institutes of Health (5R01CA221867, CCR18548501, P20GM121327)
This publication has 56 references indexed in Scilit:
- FunRich: An open access standalone functional enrichment and interaction network analysis toolProteomics, 2015
- The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancerBritish Journal of Cancer, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metageneBritish Journal of Cancer, 2010
- ERα-negative and triple negative breast cancer: Molecular features and potential therapeutic approachesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductorBioinformatics, 2007
- Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple CancersCancer Research, 2007
- A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survivalProceedings of the National Academy of Sciences, 2006
- Born to bind: the BTB protein–protein interaction domainBioEssays, 2006